Using in vitro nucleic acid selections for conventional drug design
- 1 October 1994
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 33 (2) , 102-115
- https://doi.org/10.1002/ddr.430330207
Abstract
In vitro selection of nucleic acids has typically been used for the generation of high molecular weight inhibitors of enzymes. However, this technique can also be used for more conventional drug design in several different ways. First, the binding sites of regulatory proteins on DNA or RNA can be precisely delimited using in vitro selection. Second, “artificial” phylogenices generated by this technique can be used to model the three‐dimensional structure of nucleic acids. And, finally, the technique can be used to screen large chemical libraries for new lexitropsins, compounds that can specifically recognize nucleic acid sequence or structure. © 1994 Wiley‐Less, Inc.Keywords
This publication has 59 references indexed in Scilit:
- Random peptide librariesCurrent Opinion in Biotechnology, 1994
- Modeling the Three-dimensional Structure of RNA Using Discrete Nucleotide Conformational SetsJournal of Molecular Biology, 1993
- Randomization of genes by PCR mutagenesis.Genome Research, 1992
- Sequence-selective DNA recognition by synthetic ligandsBioconjugate Chemistry, 1991
- Modelling of the three-dimensional architecture of group I catalytic introns based on comparative sequence analysisJournal of Molecular Biology, 1990
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990
- Metalloregulation in the sequence specific binding of synthetic molecules to DNAJournal of the American Chemical Society, 1987
- Evolution in vitro: Sequence and phenotype of a mutant RNA resistant to ethidium bromideJournal of Molecular Biology, 1974
- Complete Nucleotide Sequence of a Replicating RNA MoleculeScience, 1973